Antihypertensive medication prescription patterns and time trends for newly-diagnosed uncomplicated hypertension patients in Taiwan

BMC Health Services Research
Pang-Hsiang Liu, Jung-Der Wang

Abstract

Knowledge of existing prescription patterns in the treatment of newly-diagnosed hypertension can provide useful information for improving clinical practice in this field. The aims of this study are to determine the prescription patterns and time trends for antihypertensive medication in newly-diagnosed cases of uncomplicated hypertension in Taiwan and to compare these with current clinical guidelines. A total of 6,536 newly-diagnosed patients with uncomplicated hypertension, aged >/=30 years, were identified from the representative 200,000-person sample in the computerized reimbursement database of the National Health Insurance in Taiwan. These patients were followed from 1998 to 2004 with all diagnoses, prescription data and medication charges being retrieved for subsequent analysis. Prescription patterns varied by age, gender and clinical facilities, with mono-therapies being found to be dominant in the first year, albeit declining over time. Calcium channel blockers and beta-blockers were the most frequently prescribed antihypertensive drugs, either alone or in combinations. Although least expensive, the prescription rates of diuretics were low, at 8.3% for mono-therapies and 19.9% overall. The prescription rate for angioten...Continue Reading

References

Sep 1, 1990·The American Journal of Emergency Medicine·P Cummings
Jan 17, 1989·The American Journal of Cardiology·W W Neal
Apr 24, 1995·Archives of Internal Medicine·T A ManolioW B Applegate
May 22, 1996·JAMA : the Journal of the American Medical Association·D LevyK K Ho
Apr 20, 1999·Circulation·T J WangRandall S Stafford
Apr 6, 2001·The Western Journal of Medicine·B Goodman
Apr 17, 2001·Hypertension·J R SowersE D Frohlich
May 10, 2002·Pharmacoepidemiology and Drug Safety·Erik Bøg-HansenLennart Råstam
Nov 9, 2002·Lancet·Majid EzzatiComparative Risk Assessment Collaborating Group
Jan 22, 2003·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Jennifer D GuoAlex Z Fu
May 16, 2003·JAMA : the Journal of the American Medical Association·Aram V ChobanianNational High Blood Pressure Education Program Coordinating Committee
May 22, 2003·JAMA : the Journal of the American Medical Association·Bruce M PsatyNoel S Weiss
Jun 5, 2003·Journal of Hypertension·European Society of Hypertension-European Society of Cardiology Guidelines Committee
Jun 27, 2003·The Journal of Clinical Hypertension·William J Elliott
Nov 5, 2003·Journal of the Royal Society of Medicine·Tom WalleyChristie J Niziol
Nov 5, 2003·Journal of Hypertension·Judith A Whitworth, World Health Organization, International Society of Hypertension Writing Group
Dec 5, 2003·The Journal of Hospital Infection·C M PelloweGuideline Development Group
Mar 17, 2004·BMJ : British Medical Journal·Bryan WilliamsBHS guidelines working party, for the British Hypertension Society
Apr 13, 2004·Journal of Hypertension·Arya M SharmaHYDRA Study Group
Sep 15, 2004·PharmacoEconomics·Luca Degli Esposti, Giorgia Valpiani
Mar 15, 2005·BMC Health Services Research·Atle Fretheim, Andrew D Oxman
Dec 14, 2005·Hypertension·Norman R C CampbellCanadian Hypertension Education Program Outcomes Research Task Force
Dec 23, 2006·Journal of the Formosan Medical Association = Taiwan Yi Zhi·Li-Jen Cheng, Jung-Der Wang

Citations

Mar 4, 2011·International Journal of Clinical Pharmacy·Hong Cheng
Jul 11, 2012·International Journal of Clinical Pharmacy·Wei-Liang ChenChih-Chieh Chou
Aug 30, 2008·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·C-M ChenG-J Lee-Chen
Jan 18, 2012·Journal of the Formosan Medical Association = Taiwan Yi Zhi·Chiung-Jen WuP Ferrari
Nov 15, 2013·Thérapie·Ghizlane Berrada El AziziYahia Cherrah
Jan 1, 2015·Clinical Hypertension·Noah JarariLaxmi Teja Peela
Jan 17, 2009·Health Services Research·Carolyn Clancy
May 16, 2012·Journal of Evaluation in Clinical Practice·Nafees AhmadMuhammad Atif
Jul 21, 2012·Drug Metabolism and Pharmacokinetics·Chia-Hsien ChangLi-Jen Lin
Dec 17, 2014·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Jeong Bae ParkJi-Guang Wang
Jul 19, 2016·Geriatrics & Gerontology International·Sujita W Narayan, Prasad S Nishtala
Jun 13, 2012·European Journal of Preventive Cardiology·Chien-Ying LeeKuang-Hua Huang
Jan 17, 2009·Journal of Hypertension·Pang-Hsiang LiuJung-Der Wang
Sep 20, 2019·International Journal of Hypertension·Sang Hyuck KimYong-Chol Kwon
Dec 10, 2019·The Journal of Clinical Hypertension·Hao-Min ChengChen-Huan Chen
Mar 18, 2011·Current Medical Research and Opinion·B TomlinsonF Follath
Aug 30, 2018·International Journal of Analytical Chemistry·Alexander Chernonosov
Apr 18, 2013·American Journal of Hypertension·Martin C S WongSian M Griffiths

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.